MUC16 and cervical carcinoma: SERS-based lateral flow assay for simultaneous detection of SCCA and cancer antigen 125 (CA125) in serumDetection limit: 8.093 pg/mL for SCCA and 7.370 pg/mL for CA125SERS intensities at 1083 cm−1 (SCCA) and 1330 cm−1 (CA125) increased in serum from cervical cancer and precancer patients compared to healthy subjectsGood agreement between SCCA and CA125 levels measured by SERS and ELISA in serum samples